Cargando…

Identification of biomarkers in nonalcoholic fatty liver disease: A machine learning method and experimental study

Nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease. However, the early diagnosis of NAFLD is challenging. Thus, the purpose of this study was to identify diagnostic biomarkers of NAFLD using machine learning algorithms. Differentially expressed genes between NA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Na, He, Juan, Shi, Lixin, Zhang, Miao, Zheng, Jing, Fan, Yuanshuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676265/ https://www.ncbi.nlm.nih.gov/pubmed/36419827 http://dx.doi.org/10.3389/fgene.2022.1020899

Ejemplares similares

Integrated Bioinformatics Analysis Identifies Robust Biomarkers and Its Correlation With Immune Microenvironment in Nonalcoholic Fatty Liver Disease
por: Zhang, Feng, et al.
Publicado: (2022)

Investigating the Association Between Seven Sleep Traits and Nonalcoholic Fatty Liver Disease: Observational and Mendelian Randomization Study
por: Fan, Hong, et al.
Publicado: (2022)

Bioinformatics Analysis Explores Potential Hub Genes in Nonalcoholic Fatty Liver Disease
por: Wu, Chutian, et al.
Publicado: (2021)

Identification of metabolic biomarkers associated with nonalcoholic fatty liver disease
por: Jiang, Hua, et al.
Publicado: (2023)

Exploration of Shared Gene Signatures and Molecular Mechanisms Between Periodontitis and Nonalcoholic Fatty Liver Disease
por: Xu, Wanqiu, et al.
Publicado: (2022)

Identification of effective diagnostic biomarker and immune cell infiltration characteristics in acute liver failure by integrating bioinformatics analysis and machine-learning strategies
por: Yuan, Mengqin, et al.
Publicado: (2022)

Identification of Diagnostic Biomarkers in Systemic Lupus Erythematosus Based on Bioinformatics Analysis and Machine Learning
por: Jiang, Zhihang, et al.
Publicado: (2022)

Identification of biomarkers for hepatocellular carcinoma based on single cell sequencing and machine learning algorithms
por: Li, Weimin, et al.
Publicado: (2022)

Identification of biomarkers associated with diagnosis of postmenopausal osteoporosis patients based on bioinformatics and machine learning
por: Huang, Xinzhou, et al.
Publicado: (2023)

Machine learning classifiers for screening nonalcoholic fatty liver disease in general adults
por: Qin, Shenghua, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease: Diagnostic biomarkers
por: Hadizadeh, Fatemeh, et al.
Publicado: (2017)

Profile analysis and functional modeling identify circular RNAs in nonalcoholic fatty liver disease as regulators of hepatic lipid metabolism
por: Xie, Yang, et al.
Publicado: (2022)

Identification and validation of novel biomarkers associated with immune infiltration for the diagnosis of osteosarcoma based on machine learning
por: Ji, Yuqiao, et al.
Publicado: (2023)

Secreted phosphoglucose isomerase is a novel biomarker of nonalcoholic fatty liver in mice and humans
por: Lin, Huey, et al.
Publicado: (2020)

Identification of polyunsaturated fatty acids related key modules and genes in metabolic dysfunction-associated fatty liver disease using WGCNA analysis
por: Xiao, Cheng, et al.
Publicado: (2022)

Machine Learning on Human Muscle Transcriptomic Data for Biomarker Discovery and Tissue-Specific Drug Target Identification
por: Mamoshina, Polina, et al.
Publicado: (2018)

Magnetic resonance‐based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Caussy, Cyrielle, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease and early prediction of gestational diabetes mellitus using machine learning methods
por: Lee, Seung Mi, et al.
Publicado: (2022)

Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease
por: Jayasekera, Dulshan, et al.
Publicado: (2023)

Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease
por: Gîlcă-Blanariu, Georgiana-Emmanuela, et al.
Publicado: (2023)

An Accessible and Pragmatic Experimental Model of Nonalcoholic Fatty Liver Disease
por: Emamat, Hadi, et al.
Publicado: (2016)

Machine learning-based characterization of cuprotosis-related biomarkers and immune infiltration in Parkinson’s disease
por: Zhao, Songyun, et al.
Publicado: (2022)

Advances in genetic variation in metabolism-related fatty liver disease
por: Shi, Fan, et al.
Publicado: (2023)

Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
por: Pirola, Carlos J, et al.
Publicado: (2018)

Machine Learning-Based Identification of Potentially Novel Non-Alcoholic Fatty Liver Disease Biomarkers
por: Shafiha, Roshan, et al.
Publicado: (2021)

Association of liver biomarkers and cytokeratin-18 in Nonalcoholic fatty liver disease patients
por: Altaf, Benash, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis
por: Sinn, Dong Hyun, et al.
Publicado: (2016)

Identification of Cuproptosis-Related Genes in Nonalcoholic Fatty Liver Disease
por: Wu, Chutian, et al.
Publicado: (2023)

Identification of high-risk subjects in nonalcoholic fatty liver disease
por: Stern, Christiane, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Experimental Data on the Role of Melatonin in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Terziev, Dimitar, et al.
Publicado: (2023)

Bioinformatic analysis and machine learning to identify the diagnostic biomarkers and immune infiltration in adenomyosis
por: Liu, Dan, et al.
Publicado: (2023)

Identification and validation of disulfidptosis-associated molecular clusters in non-alcoholic fatty liver disease
por: Yu, Xiaoxiao, et al.
Publicado: (2023)

Editorial: Finding New Epigenomics and Epigenetics Biomarkers for Complex Diseases and Significant Developmental Events With Machine Learning Methods
por: Xie, Lu, et al.
Publicado: (2022)

EnRank: An Ensemble Method to Detect Pulmonary Hypertension Biomarkers Based on Feature Selection and Machine Learning Models
por: Liu, Xiangju, et al.
Publicado: (2021)

Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome
por: Castillo-Castro, Carolina, et al.
Publicado: (2021)

Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease
por: Kim, Tae Hyung, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle Interventions
por: Notarnicola, Maria, et al.
Publicado: (2021)

Obesity Modifies the Performance of Fibrosis Biomarkers in Nonalcoholic Fatty Liver Disease
por: Qadri, Sami, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_st13n7t6ru1igo9k5ridnaom89